orgenesis.com (ORGS): Short-Term Debt to Equity Ratio

Orgenesis Inc - graphic logo of issuer ORGS

This daily price chart for Orgenesis Inc. (ORGS) captures the value at 0.00. The business relies on IT patent protection and strict FDA compliance when establishing cell factories. The monetization model is based on optimizing clinic costs, although pricing power is limited by the complexity of expansion. Meanwhile, the company competes with large laboratory networks for startup contracts.

Orgenesis Inc - ORGS Short-Term Debt to Equity Ratio (period 07/04/2022 - 10/26/2024)

Analytical breakdowns for orgenesis.com (ORGS)

- price and consensus price forecast:
Stock Quotes Orgenesis Corp|ORGS - Analyst Forecast Prices
- market capitalization data:
Market Valuation Orgenesis Inc|ORGS - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Orgenesis|ORGS - Company Net Assets|Market Capitalization to Book Value Ratio orgenesis.com|ORGS - Company Assets
- debt and liquidity data:
Total Debt to Capital Orgenesis Inc.|ORGS - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Orgenesis|ORGS - Company Cumulative Debt|Debt to Book Capitalization Ratio Orgenesis Inc|ORGS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Orgenesis
General company analysis:Orgenesis Inc.
Original product of Orgenesis

Weak operational cash generation at Orgenesis Inc. (ORGS) due to revenue volatility within the Inertia platform makes the dynamics of short-term loans relative to equity a critical solvency indicator, where the ratio of liabilities with a maturity of over one year to capital determines the business's dependence on debt financing and the risk of liquidity gaps given the high cost of supporting current processes.

Analysis of competing companies

Short-Term Debt to Equity Ratio Veeva Systems Inc|Short-Term Loans to Capital Ratio Doximity Network DOCS|Short-Term Debt to Equity Ratio HealthEquity, Inc.|waystar.com - Ratio of Short-Term Indebtedness to Capital|CRVL: Short-Term Debt to Equity|PRVA - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital HURN|Certara Software (CERT) - Current Liabilities to Capital|Short-Term Debt to Capital Omnicell, Inc. (OMCL)|Short-Term Debt to Capital Ratio GDRX|Schrödinger - Short-Term Debt to Equity|Current Liabilities to Capital PHR (Phreesia Inc)|Short-Term Debt to Equity Omada Health Corp|Ratio of Short-Term Indebtedness to Capital Evolent Corp EVH|Short-Term Debt to Capital HSTM|DH - Short-Term Indebtedness to Equity|Short-Term Debt to Capital CCSI|AGL (agilon health, inc.) - Current Liabilities to Capital|Short-Term Debt to Equity Absci Corp. (ABSI)|Short-Term Debt to Capital Ratio So-Young Corp|NRC Health - Short-Term Debt to Capital|Current Liabilities to Capital SPOK (spok.com)|Short-Term Debt to Equity OPRX|Short-Term Debt to Capital Coefficient TruBridge Inc TBRG|Short-Term Debt to Capital SLP (Simulations Plus Corp)|SOPH: Short-Term Debt to Capital Coefficient|Health Catalyst, Inc. - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient CareCloud|RSSS - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital DLH Holdings Corp|ONMD (OneMedNet Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient SCNX (Scienture Corp)|HCTI - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio iSpecimen Inc ISPC|BFRG: Short-Term Debt to Capital|SCWorx Corp (WORX) - Short-Term Debt to Equity Ratio|LifeWallet - Short-Term Debt to Equity Ratio|ICCT (iCoreConnect) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity MEDS (TRxADE HEALTH, Inc.)|Current Liabilities to Capital RCM|Sharecare (SHCR) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Streamline Health Solutions, Inc. (STRM)|SYRA (Syra Health Corporation) - Short-Term Debt to Capital|Apollo Medical Holdings Inc. - Short-Term Indebtedness to Equity|Short-Term Debt to Equity MODN (Model N, Inc.)|NXGN - Short-Term Debt to Capital Coefficient